BSX
64
-3
DE
42
3
HBI
58
3
VRTX
47
-6
SNA
70
-5
SWKS
38
-2
ORLY
60
-5
URI
60
-6
CTSH
60
-3
CAG
24
-3
GT
56
-3
HST
39
-3
LRCX
37
-9
SEE
53
3
KR
36
-6
ETR
65
2
NWS
75
-4
K
51
-3
CMG
66
-4
VRSK
68
-12
BSX
64
-3
DE
42
3
HBI
58
3
VRTX
47
-6
SNA
70
-5
SWKS
38
-2
ORLY
60
-5
URI
60
-6
CTSH
60
-3
CAG
24
-3
GT
56
-3
HST
39
-3
LRCX
37
-9
SEE
53
3
KR
36
-6
ETR
65
2
NWS
75
-4
K
51
-3
CMG
66
-4
VRSK
68
-12
Financhill
Back

IDEXX Laboratories Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
43

IDXX
IDEXX Laboratories

Last Price:
421.30
Seasonality Move:
8.03%
Sell
33

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
43
IDEXX Laboratories (IDXX) is a Sell

Is IDEXX Laboratories a Buy, Sell or Hold?

  • The current IDEXX Laboratories [IDXX] share price is $420.91. The Score for IDXX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • IDXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IDXX Stock Price Chart

What is IDEXX Laboratories's stock price today?

  • The IDEXX Laboratories share price today is $420.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDXX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

IDXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.4 Sell
Relative Strength Index (14 RSI): 36.25 Sell
Chaikin Money Flow: 371096 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (421.97 - 462.61) Sell
Bollinger Bands (100): (450.37 - 498.75) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -8154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.27 - 1.57) Sell

IDXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 428.45 Sell
20-day SMA: 435.37 Sell
50-day SMA: 468.57 Sell
200-day SMA: 498.82 Sell
8-day EMA: 427.03 Sell
20-day EMA: 437.01 Sell
50-day EMA: 456.79 Sell
200-day EMA: 483.55 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.44 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.82 Sell

IDEXX Laboratories Earnings Growth & IDXX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $1.12 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

IDEXX Laboratories Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):